Expert Opinion on Biological Therapy

OCT 16, 2026 · JOURNAL ARTICLE

An evaluation of sacituzumab tirumotecan for the treatment of NSCLC

Expert Opinion on Biological Therapy

INTRODUCTION: Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality, and resistance to targeted therapy and immunotherapy represents a substantial

AUG 17, 2026 · JOURNAL ARTICLE

Expanding indications of immune checkpoint inhibitors: a decade of success going strong

Expert Opinion on Biological Therapy

A narrative literature review synthesizing a decade of ICI expansion across oncology, offering expert opinion on established indications and future directions rather than reporting original trial results.

JUL 25, 2026 · JOURNAL ARTICLE

Gene therapy approaches for inborn errors of immunity: from bench to bedside

Expert Opinion on Biological Therapy

A narrative review synthesizing 30 years of gene therapy evolution for inborn errors of immunity, tracing technological advances and identifying barriers to clinical translation, rather than presenting new primary evidence.